Department of Otolaryngology, Fengdu County People's Hospital, Chongqing, China.
Department of Stomatology, Fengdu County People's Hospital, Chongqing, China.
Front Public Health. 2024 Jan 5;11:1267764. doi: 10.3389/fpubh.2023.1267764. eCollection 2023.
Mental health risks associated with the aftermath of the COVID-19 pandemic are often overlooked by the public. The aim of this study was to investigate the effects of the COVID-19 pandemic on depression and anxiety disorders in China.
Studies were analyzed and extracted in accordance with the PRISMA 2020 flowchart. The studies were screened and extracted using electronic databases including PubMed, Web of Science, Embase, Cochrane Library, and ClinicalTrials.gov according to the predefined eligibility criteria. The Cochrane Review Manager software 5.3.1 was used for data analysis and the risk of bias assessment.
As of 2023, a total of 9,212,751 Chinese have been diagnosed with COVID-19 infection. A total of 913,036 participants in 44 studies were selected following the eligibility criteria, the statistical information of which was collected for meta-analysis. The pooled prevalence of depression and anxiety were 0.31 (95% CI: 0.28, 0.35; = 100.0%, < 0.001) and 0.29 (95% CI: 0.23, 0.36; = 100.0%, < 0.001), respectively. After performing a subgroup analysis, the prevalence of depression among women, healthcare workers, students, and adolescents was 0.31 (95% CI: 0.22, 0.41), 0.33 (95% CI: 0.26, 0.44), 0.32 (95% CI: 0.26, 0.39), and 0.37 (95% CI: 0.31, 0.44), respectively.
The prevalence of depression and anxiety among the Chinese was overall high. Monitoring and surveillance of the mental health status of the population during crises such as sudden global pandemics are imperative.
https://clinicaltrials.gov/, identifier [CRD42023402190].
公众经常忽视与 COVID-19 大流行后果相关的心理健康风险。本研究旨在调查 COVID-19 大流行对中国抑郁和焦虑障碍的影响。
根据 PRISMA 2020 流程图对研究进行分析和提取。根据预定义的纳入标准，使用电子数据库（包括 PubMed、Web of Science、Embase、Cochrane Library 和 ClinicalTrials.gov）筛选和提取研究。使用 Cochrane Review Manager 软件 5.3.1 进行数据分析和偏倚风险评估。
截至 2023 年，中国共有 9212751 人被诊断出 COVID-19 感染。根据纳入标准，共选择了 44 项研究中的 913036 名参与者，收集了其统计信息进行荟萃分析。抑郁和焦虑的总患病率分别为 0.31（95%CI：0.28，0.35；=100.0%，<0.001）和 0.29（95%CI：0.23，0.36；=100.0%，<0.001）。进行亚组分析后，女性、医护人员、学生和青少年的抑郁患病率分别为 0.31（95%CI：0.22，0.41）、0.33（95%CI：0.26，0.44）、0.32（95%CI：0.26，0.39）和 0.37（95%CI：0.31，0.44）。
中国人群的抑郁和焦虑患病率总体较高。在突发的全球大流行等危机期间，对人口的心理健康状况进行监测和监测至关重要。
https://clinicaltrials.gov/，标识符 [CRD42023402190]。
